LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the fourth quarter and full year ended December 31, 2025 and initiated full year 2026 Revenue and Adjusted EBITDA1 guidance. Fourth Quarter 2025 Financial Highlights(note: all figures represent continuing operations and exclude the Community Living b ...

Performance was driven by a 13% revenue increase, with acute therapies growing in the mid-teens and chronic therapies in the low double digits despite biosimilar headwinds. Management attributed the 160 basis point revenue headwind in 2025 to patient transitions toward Stelara biosimilars, which carry lower reference prices and reimbursement rates. Strategic positioning as the nation's largest independent provider allowed the company to serve over 315,000 unique patients, leveraging 50-state licensure ...

Management discussed ongoing investments in automation and artificial intelligence, particularly within revenue cycle functions. Rademacher said the company has automated key patient administration tasks such as invoice processing and cash posting, and that about 40% of claims are processed without human intervention. In response to questions, executives said AI use cases are expanding beyond revenue cycle management to areas including call center/customer service “agentic” tools, workforce optimization, an ...

In hospice, same-store revenue increased 16% year over year, with average daily census rising to 3,885 from 3,472. Allison said median length of stay (including the Illinois JourneyCare operation) was 25 days in the fourth quarter, up from 22 days in the third quarter. Dixon later attributed length-of-stay improvement to efforts to diversify referral sources market by market and said the company saw improvement in its overall hospice CAP position in the quarter, including a benefit that she characterized as ...

Addus HomeCare (NasdaqGS:ADUS) Q4 2025 Earnings call February 24, 2026 09:00 AM ET Company ParticipantsA.J. Rice - Managing Director of Equity ResearchAndrew Mok - Director of Equity ResearchBrian Poff - EVP and CFOClarke Murphy - VP of Equity ResearchDirk Allison - Chairman and CEODru Anderson - Senior PartnerHeather Dixon - President and COOJared Haase - Equity Research AssociateJohn Ransom - Managing Director of Healthcare Equity ResearchRaj Kumar - Managing DirectorConference Call ParticipantsBen Hendri ...

Addus HomeCare (NasdaqGS:ADUS) Q4 2025 Earnings call February 24, 2026 09:00 AM ET Speaker13Note, this event is being recorded. I would now like to turn the conference over to Drew Anderson. Please go ahead.Speaker7Thank you. Good morning, and welcome to the Addus HomeCare Corporation fourth quarter and 2025 earnings conference call. Today's call is being recorded. To the extent any non-GAAP financial measure is discussed in today's call, you will also find a reconciliation of that measure to the most direc ...

Accendra Health Inc. (NYSE:ACH) is one of the most undervalued penny stocks to buy right now. On February 19, Accendra Health reported full-year 2025 revenue of nearly $2.8 billion, which was a 3% year-over-year increase. Despite this growth, Q4 adjusted EBITDA fell to $90 million from $102.5 million in the prior year, bringing the annual total to $375 million. This progress was supported by the sale of the company’s former products and healthcare services business, allowing the firm to focus on its core h ...

Option Care Health (NasdaqGS:OPCH) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsErin Wright - Managing DirectorJohn Rademacher - President and CEOLisa Gill - Managing DirectorMeenal Sethna - EVP and CFONicole Maggio - Senior Vice President, Corporate ControllerConference Call ParticipantsAlbert Rice - Managing Director and Senior Health Care Equity Research AnalystBrian Tanquilut - Managing Director and Senior Equity Research AnalystCharles Rhyee - Managing Director and Senior Res ...

Option Care Health (NasdaqGS:OPCH) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsErin Wright - Managing DirectorJohn Rademacher - President and CEOLisa Gill - Managing DirectorMeenal Sethna - EVP and CFONicole Maggio - Senior Vice President, Corporate ControllerConference Call ParticipantsAlbert Rice - Managing Director and Senior Health Care Equity Research AnalystBrian Tanquilut - Managing Director and Senior Equity Research AnalystCharles Rhyee - Managing Director and Senior Res ...

Financial Supplement Q4 2025 Disclaimer This presentation contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management's current views concerning future business, events, trends, contingencies, financial performance, or financial condition, appear at various places in this communication and may use words like "aim," "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "forecast," "future," "goal, ...